Pilot, Multicenter, Open-Label Evaluation of Safety, Tolerability and Efficacy of a Novel, Topical Multipotent Growth Factor Formulation for the Periorbital Region.

Sundaram, Hema; Gold, Michael; Waldorf, Heidi; Lupo, Mary; Nguyen, Vivien L; Karnik, Jwala

Sundaram, Hema; Gold, Michael; Waldorf, Heidi; Lupo, Mary; Nguyen, Vivien L; Karnik, Jwala.

J Drugs Dermatol ; 14(12): 1410-7, 2015 Dec.

Article in En | MEDLINE | ID: mdl-26659933

Subject(s)

Intercellular Signaling Peptides and Proteins/adverse effects; Intercellular Signaling Peptides and Proteins/therapeutic use; Orbit; Skin Aging/drug effects; Skin/drug effects; Administration, Topical; Aged; Female; Humans; Intercellular Signaling Peptides and Proteins/administration & dosage; Middle Aged; Patient Satisfaction; Pilot Projects; Rejuvenation; Skin Pigmentation; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Orbit / Skin / Skin Aging / Intercellular Signaling Peptides and Proteins Type of study: Clinical_trials Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2015 Type: Article

Search on Google

XML

PubMed Links